It’s important for patients to have as much information as they want to know about their disease so that they can make decisions about their care based on knowledge. Today the treatment outlook for patients with multiple myeloma has never been brighter, however, the many new drugs that are now available and the soon to be approved drugs on the horizon makes choosing the right combinations somewhat complicated. By learning about their illness and the many treatments available, patients can receive the best most up to date care while minimizing the side effects of therapy.
Medical School: Northwestern University Medical School, 1973
Internship: Washington University School of Medicine, 1974
Residency: University of Washington School of Medicine, Oncology/Hematology, 1979